Looking to publish in Gastric Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginGastric Cancer is a high-level global forum dedicated to all areas of research, treatment, and biology relevant to gastric cancer. It welcomes original articles, case reports, short communications, technical notes, and Letters to the Editor, while review articles are primarily solicited by the Editor.
Looking to publish in Gastric Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Gastric Cancer accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Review Articles
Meta-Analysis Studies
Case Reports
Short Communications
Letters To The Editor
Recent Publications
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G
Toshiki Masuishi, Hiroki Hara, Takayuki Ando, Takeshi Kawakami, Yoshiyuki Yamamoto, Naotoshi Sugimoto, Kazuhiro Shiraishi, Taito Esaki, Yuji Negoro, Takao Tsuzuki, Hiroaki Sawai, Masato Nakamura, Takashi Inagaki, Yudai Shinohara, Kentaro Kawakami, Seiichiro Mitani, Kenji Tsuchihashi, Chihiro Kondoh, Hiroo Katsuya, Osamu Maeda, Yuriko Fujita, Kenichi Yoshimura, Masanori Terashima, Takako Eguchi Nakajima, Kei Muro
Prognosis-predicting factor of gastrectomy after systemic cancer therapy for cStage IVB gastric cancer
Takumi Habu, Takahiro Kinoshita, Daiki Terajima, Izuma Nakayama, Masahiro Yura, Mitsumasa Yoshida, Naoya Sakamoto, Takeshi Kuwata, Kohei Shitara
Correction: Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects
Komei Kuge, Junko Mukohyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura
Primary outcomes of a phase II trial of laparoscopic/robotic total gastrectomy with spleen-preserving splenic hilar dissection for locally advanced proximal gastric cancer involving the greater curvature (JCOG1809)
Takahiro Kinoshita, Masayuki Yokoyama, Junya Kitadani, Takeshi Omori, Souya Nunobe, Shinji Kuroda, Michitaka Honda, Haruhiko Cho, Masaki Aizawa, Yukinori Kurokawa, Tomoya Tsukada, Shusuke Haruta, Kazunari Misawa, Kazuhisa Ehara, Kota Kawabata, Masanori Terashima, Takaki Yoshikawa
Mesenchymal R-spondin 3 promotes an immunogenic tumor microenvironment with adaptive immune resistance in human gastric adenocarcinoma
Anne-Sophie Fischer, Alexander Arnold, Hilmar Berger, Stefanie Müllerke, Jonas Wizenty, Hans-Joachim Mollenkopf, David Horst, Frank Tacke, Christoph Treese, Michael Sigal
Frequently asked questions
How long does it take to publish?
Prospective randomized controlled trials must be registered within 6 months from first patient enrollment. Articles are published online after receipt of corrected proofs.
Reformat to Gastric Cancer using Livewrite PremiumIs a cover letter required?
A submission letter is referenced for reviewer suggestions and for transparency on reuse of material and unpublished material included in the manuscript.
Reformat to Gastric Cancer using Livewrite PremiumWhat are the publication costs?
Open access APC: £3690.00 GBP / $5690.00 USD / €4390.00 EUR. Subscription publishing has no APC charges.
Reformat to Gastric Cancer using Livewrite Premium